Literature DB >> 24819581

Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia.

Shusuke Ueda1, Toru Ichiseki, Yasuo Yoshitomi, Hideto Yonekura, Yoshimichi Ueda, Ayumi Kaneuji, Tadami Matsumoto.   

Abstract

Osteonecrosis is a major glucocorticoid-induced complication in the orthopedics field. Despite the extensive researches, mechanisms underlining the glucocorticoid-induced osteonecrosis are largely unknown. Here, we first provide the evidence that a combined treatment of cultured osteocytic cells with glucocorticoid and hypoxia caused necrotic cell death, which is assumed to occur in the acute bone injuries induced by glucocorticoids. We cultured MLO-Y4 murine osteocytic cells under hypoxia in the presence or absence of Dexamethasone (Dex) and examined the rates of apoptotic and necrotic cell death. Dex or hypoxia alone increased apoptotic cells, but not necrotic cells. The combination of Dex and hypoxia dramatically increased osteocytic cell death, notably necrotic cell death. The expression of Dickkopf-1 (Dkk-1), an inhibitor of Wnt/β-catenin signal, was scarcely expressed in the control and hypoxic cells, but a dramatic increase of the Dkk-1 expression was detected in Dex-treated cells. siRNA-mediated knockdown of Dkk-1 in Dex and hypoxia-treated osteocytic cells showed the significant decreases in both apoptotic and necrotic cells. The results indicated that the combination of Dkk-1 overexpression by Dex and hypoxia causes the necrotic osteocytic cell death. The results also indicated that blocking of Dkk-1 can protect bone cells from glucocorticoid and hypoxia-induced cell injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24819581     DOI: 10.1007/s00795-014-0077-9

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  30 in total

Review 1.  [Glucocorticoid-induced reduction in NO bioavailability and vascular endothelial dysfunction].

Authors:  Masashi Akaike; Toshio Matsumoto
Journal:  Clin Calcium       Date:  2007-06

2.  Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits.

Authors:  G J Wang; D E Sweet; S I Reger; R C Thompson
Journal:  J Bone Joint Surg Am       Date:  1977-09       Impact factor: 5.284

3.  DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis.

Authors:  T Ichiseki; A Kaneuji; S Katsuda; Y Ueda; T Sugimori; T Matsumoto
Journal:  Rheumatology (Oxford)       Date:  2004-12-14       Impact factor: 7.580

4.  Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin.

Authors:  K Jähn; N Lara-Castillo; L Brotto; C L Mo; M L Johnson; M Brotto; L F Bonewald
Journal:  Eur Cell Mater       Date:  2012-09-12       Impact factor: 3.942

Review 5.  Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.

Authors:  Maurizio Rossini; Davide Gatti; Silvano Adami
Journal:  Calcif Tissue Int       Date:  2013-06-11       Impact factor: 4.333

6.  Establishment of an osteocyte-like cell line, MLO-Y4.

Authors:  Y Kato; J J Windle; B A Koop; G R Mundy; L F Bonewald
Journal:  J Bone Miner Res       Date:  1997-12       Impact factor: 6.741

7.  Oxidative stress and vascular permeability in steroid-induced osteonecrosis model.

Authors:  Toru Ichiseki; Tadami Matsumoto; Mitsuru Nishino; Ayumi Kaneuji; Shogo Katsuda
Journal:  J Orthop Sci       Date:  2004       Impact factor: 1.601

8.  Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation.

Authors:  Joseph S Butler; Joseph M Queally; Brian M Devitt; David W Murray; Peter P Doran; John M O'Byrne
Journal:  BMC Musculoskelet Disord       Date:  2010-09-15       Impact factor: 2.362

9.  Fat embolism, intravascular coagulation, and osteonecrosis.

Authors:  J P Jones
Journal:  Clin Orthop Relat Res       Date:  1993-07       Impact factor: 4.176

10.  The effect of dexamethasone and hypoxic stress on MC3T3-E1 cells.

Authors:  Zhen-Hong Zhu; You-Shui Gao; Bing-Fang Zeng; Chang-Qing Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01
View more
  7 in total

Review 1.  The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Authors:  Huayue Chen; Takao Senda; Kin-ya Kubo
Journal:  Med Mol Morphol       Date:  2015-03-20       Impact factor: 2.309

2.  Heme oxygenase-1 prevents glucocorticoid and hypoxia-induced apoptosis and necrosis of osteocyte-like cells.

Authors:  Hiroki Yamamoto; Masazumi Saito; Tsuyoshi Goto; Keiichiro Ueshima; Masashi Ishida; Shigeki Hayashi; Kazuya Ikoma; Osam Mazda; Toshikazu Kubo
Journal:  Med Mol Morphol       Date:  2019-01-31       Impact factor: 2.309

3.  Wnt/β-catenin signaling reduces Bacillus Calmette-Guerin-induced macrophage necrosis through a ROS -mediated PARP/AIF-dependent pathway.

Authors:  Xiaoling Wu; Guangcun Deng; Min Li; Yong Li; Chunyan Ma; Yujiong Wang; Xiaoming Liu
Journal:  BMC Immunol       Date:  2015-03-18       Impact factor: 3.615

4.  Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions.

Authors:  Jian-Hang Wang; Yuanjin Zhang; Hong-Yan Li; Yun-Yan Liu; Tao Sun
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 5.  Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects.

Authors:  Katalin Meszaros; Attila Patocs
Journal:  Molecules       Date:  2020-03-25       Impact factor: 4.411

6.  Mitochondrial Transcription Factor A added to Osteocytes in a Stressed Environment has a Cytoprotective Effect.

Authors:  Shusuke Ueda; Miyako Shimasaki; Toru Ichiseki; Hiroaki Hirata; Norio Kawahara; Yoshimichi Ueda
Journal:  Int J Med Sci       Date:  2020-05-23       Impact factor: 3.738

7.  Taurine Inhibits Glucocorticoid-Induced Bone Mitochondrial Injury, Preventing Osteonecrosis in Rabbits and Cultured Osteocytes.

Authors:  Hiroaki Hirata; Shusuke Ueda; Toru Ichiseki; Miyako Shimasaki; Yoshimichi Ueda; Ayumi Kaneuji; Norio Kawahara
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.